Identification of active antiviral compounds against a New York isolate of West Nile virus (Q38884300)

7 September 2017

Identification of active antiviral compounds against a New York isolate of West Nile virus (English)

1 reference

7 September 2017

0 references

2

Donald F Smee

1 reference

7 September 2017

1

John D Morrey

1 reference

7 September 2017

Robert W Sidwell

3

1 reference

PubMed ID

12076755

7 September 2017

Christopher Tseng

series ordinal

4

1 reference

7 September 2017

1 July 2002

1 reference

7 September 2017

1 reference

7 September 2017

55

1 reference

7 September 2017

1

1 reference

7 September 2017

107-116

1 reference

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Antiviral action and selectivity of 6-azauridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Sindbis virus mutants resistant to mycophenolic acid and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Evaluation of 6-Azauridine and S-Iododeoxyuridine in the Treatment of Experimental Viral Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Therapeutic effect of the antiviral agent ribavirin in Junín virus infection of primates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

Comparison of the anti-respiratory syncytial virus activity and toxicity of papaverine hydrochloride and pyrazofurin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900013-X

7 January 2021

10.1016/S0166-3542(02)00013-X

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

12076755